Fluidigm Preliminary Q3 Results Show 23 Percent Drop in Revenue

Oct 12, 2016

|

NEW YORK (GenomeWeb) – Fluidigm announced after the close of the markets on Wednesday that it will suspend its full-year 2016 revenue guidance based on its assessment of third quarter revenues.

According to management's preliminary analysis, the firm said, revenues for the three months ended Sept. 30 fell approximately 23 percent year over year, to $22.2 million from $28.6 million. Wall Street analysts had expected revenues of $29.3 million for the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Not Always an Answer

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

CRISPR Acceptance or Not?

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

This Week in Science

In Science this week: research regulation and reporting requirement reform, and more.

Building Up Numbers

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Main menu